Articles

The prevalence of epidermal skin malignancies in people living with oculocutaneous albinism attending the Universitas Academic Hospital, Bloemfontein, South Africa

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 6 May 2024
Accepted: 11 May 2025
Published: 4 December 2025
309
Views
138
Downloads

Authors

Oculocutaneous albinism (OCA) is a group of heterogeneous genetic disorders caused by the absence or reduced biosynthesis of melanin pigment within the melanocytes in the epidermis. Patients with OCA are prone to certain types of epidermal skin cancers, premalignant skin lesions, and eye-related symptoms and signs. The study aimed to evaluate the prevalence of common epidermal skin cancers and premalignant skin lesions in patients living with OCA attending an academic hospital in Bloemfontein, Free State province (South Africa). This research focused on individuals referred within the public health sector. We evaluated all patients with this specific condition across the entire Free State province of South Africa and in Lesotho. The study was conducted as a cross-sectional, retrospective review of the medical records of all patients known to the clinic, as well as those referred with OCA, from January 2017 to January 2019. A total of 36 patients were included in this study, with 11 (30.6%) males and 25 (69.4%) females. Thirty-two (88.9%) had a history of active or past epidermal skin cancers or pre-malignant skin lesions, while the remaining 4 (11.1%) had no history of secondary skin pathology. The distribution of the pathology was notable in relation to sun exposure, with the face being mostly affected in 31 (96.9%) of cases assessed. OCA has been identified as a risk factor for solar keratosis, squamous cell carcinoma (SCC), and basal cell carcinoma (BCC).

Downloads

Download data is not yet available.

Citations

1. Galli J, Loi E, Dusi L, et al. Oculocutaneous albinism: the neurological, behavioral, and neuroophthalmological perspective. Eur J Pediatr 2023;182:2723-33. DOI: https://doi.org/10.1007/s00431-023-04938-w
2. Levin AV, Stroh E. Albinism for the busy clinician. J AAPOS 2011;15:59-66. DOI: https://doi.org/10.1016/j.jaapos.2010.10.012
3. Oetting WS, Brilliant MH, King RA. The clinical spectrum of albinism in humans. Mol Med Today 1996;2:330-5. DOI: https://doi.org/10.1016/1357-4310(96)81798-9
4. Kruijt CC, de Wit GC, Bergen AA, et al. The phenotypic spectrum of albinism. Ophthalmology 2018;125:1953-60. DOI: https://doi.org/10.1016/j.ophtha.2018.08.003
5. GrØnskov K, Ek J, Brondum-Nielsen K. Oculocutaneous albinism. Orphanet J Rare Dis 2007;2:43. DOI: https://doi.org/10.1186/1750-1172-2-43
6. Federico JR, Krishnamurthy K. Albinism. [Updated 2023 Aug 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK519018
7. Oetting WS, King RA. Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism. Hum Mutat 1999;13:99-115. DOI: https://doi.org/10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.0.CO;2-C
8. Wei AH, Zang DJ, Zhang Z, et al. Exome sequencing identifies SLC24A5 as a candidate gene for non-syndromic oculocutaneous albinism. J Invest Dermatol 2013;133:1834-40. DOI: https://doi.org/10.1038/jid.2013.49
9. Pennamen P, Tingaud-Sequeira A, Gazova I, et al. Dopachrome tautomerase variants in patients with oculocutaneous albinism. Genet Med 2021;23:479-87. DOI: https://doi.org/10.1038/s41436-020-00997-8
10. Kausar T, Bhatti MA, Ali M, et al. OCA5, a novel locus for non-syndromic oculocutaneous albinism, maps to chromosome 4q24. Clin Genet 2013;84:91-3. DOI: https://doi.org/10.1111/cge.12019
11. Kiprono SK, Chaula BM, Beltraminelli H. Histological review of skin cancers in African Albinos: a 10-year retrospective review. BMC Cancer 2014;14:157. DOI: https://doi.org/10.1186/1471-2407-14-157
12. Merideth MA, Introne WJ, Wang JA, et al. Genetic variants associated with Hermansky-Pudlak syndrome. Platelets 2020;31:544-7. DOI: https://doi.org/10.1080/09537104.2019.1663810
13. Lozano ML, Rivera J, Sánchez-Guiu I, Vicente V. Towards the targeted management of Chediak-Higashi syndrome. Orphanet J Rare Dis 2014;9:132. DOI: https://doi.org/10.1186/s13023-014-0132-6
14. Perry PK, Silverberg NB. Cutaneous malignancy in albinism. Cutis 200;67:427-30.
15. Binesh F, Akhavan A, Navabii H. Nevoid malignant melanoma in an albino woman. BMJ Case Rep 2010;2010:bcr0820103262. DOI: https://doi.org/10.1136/bcr.08.2010.3262
16. Thomas MG, Zippin J, Brooks BP. Oculocutaneous Albinism and Ocular Albinism Overview. 2023 Apr 13. In: Adam MP, Bick S, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK590568/
17. Awe OO, Azeke TA. Cutaneous Cancers in Nigerian Albinos: A Review of 22 Cases. Niger J Surg 2018;24:34-8. DOI: https://doi.org/10.4103/njs.NJS_23_17
18. Lekalakala PT, Khammissa RA, Kramer B, et al. Oculocutaneous Albinism and Squamous Cell Carcinoma of the Skin of the Head and Neck in Sub-Saharan Africa. J Skin Cancer 2015;2015:167847. DOI: https://doi.org/10.1155/2015/167847
19. Maunganidze F, Machiha K, Mapuranga M. Employment barriers and opportunities faced by people with albinism. A case of youths with albinism in Harare, Zimbabwe. Cogent Soc Sci 2022;8. DOI: https://doi.org/10.1080/23311886.2022.2092309
20. Tambala-Kaliati T, Adomako EB, Frimpong-Manso K. Living with albinism in an African community: exploring the challenges of persons with albinism in Lilongwe District, Malawi. Heliyon 2021;7:e07034. DOI: https://doi.org/10.1016/j.heliyon.2021.e07034
21. Mapurisa G, Masamba L. Locally advanced skin cancer in an albino: a treatment dilemma. Malawi Med J 2010;22:122-3. DOI: https://doi.org/10.4314/mmj.v22i4.63949
22. Alexander GA, Henschke UK. Advanced skin cancer in Tanzanian albinos: preliminary observations. J Natl Med Assoc 1981;73:1047-54.
23. Makhakhe L. African atlas, synopsis and practical guide to clinical dermatology. 1st ed. Bloemfontein: African Brilliant Minds Publishers; 2020. ISBN: 978-0-6399539-1-5.
24. Hong ES, Zeeb H, Repacholi MH. Albinism in Africa as a public health issue. BMC Public Health 2006;6:212. DOI: https://doi.org/10.1186/1471-2458-6-212

How to Cite



1.
Makhakhe L, Oliver B-J, Motloung M, Ngaka Z, Motaung Z, Chabeli M, et al. The prevalence of epidermal skin malignancies in people living with oculocutaneous albinism attending the Universitas Academic Hospital, Bloemfontein, South Africa. Dermatol Reports [Internet]. 2025 Dec. 4 [cited 2026 Mar. 11];. Available from: https://journals.pagepress.net/dr/article/view/10038